Concerned about your investment in Spotlight Innovation, Inc.?
If your financial advisor unsuitably recommended investing in Spotlight Innovation, Inc. and you incurred losses, you may be able to recover your losses by filing a FINRA Arbitration claim.
Spotlight Innovation Inc., a pharmaceutical holding company headquartered in Urbandale, Iowa, reportedly has two subsidiaries: Caretta Therapeutics, Inc. and Celtic Biotech Iowa, Inc., according to Reuters.
The company reportedly filed a Form D to raise capital from investors in 2016. The total offering amount was purportedly $2,500,000.
According to filings with the SEC, the company has failed to file quarterly reports with the regulator since October 2018.
Filing a Complaint against your Brokerage Firm
Unfortunately brokers may not always adequately explain the risks and liquidity problems involved in purchasing alternative investments.
These investments are considerably more risky than traditional investments such as stocks, bonds, or mutual funds. They also often come with high fees and commissions. In this case, the estimated sales commissions paid to the broker-dealers were 7% and the selling agent received an underwriting fee of 3%.
The White Law Group is investigating the liability that some broker dealers may have for improperly recommending Spotlight Innovation Inc. to investors.
Your financial advisor has a responsibility to perform due diligence on any investment before recommending it to you. If your advisor made unsuitable recommendations to you and you lost money, the securities attorneys at The White Law Group may be able to help you by filing a FINRA Arbitration claim against the brokerage firm that sold you the investment.
For a free consultation with a securities attorney, please call the offices at 888-637-5510.
The White Law Group, LLC is a national securities fraud, securities arbitration, investor protection, and securities regulation/compliance law firm with offices in Chicago, Illinois.
Please visit our website for more information on the firm, www.whitesecuritieslaw.com.